Gane, Edward J <br/><br/>
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  May 2011 
 - 676-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/j.1478-3231.2011.02490.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Alanine Transaminase--blood<br/>Antiviral Agents--administration & dosage<br/>Biomarkers--blood<br/>DNA, Viral--blood<br/>Drug Administration Schedule<br/>Drug Resistance, Viral--genetics<br/>Female<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--immunology<br/>Hepatitis B, Chronic--diagnosis<br/>Humans<br/>Male<br/>Middle Aged<br/>Nucleosides--administration & dosage<br/>Pyrimidinones--administration & dosage<br/>Telbivudine<br/>Thymidine--analogs & derivatives<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult